Abstract:Tumor cell heterogeneity mediated drug resistance has been recognized as the stumbling block of cancer treatment. Elucidating the cytotoxicity of anticancer drugs at single-cell level in a high-throughput way is thus of great value for developing precision therapy. However, current techniques suffer from limitations in dynamically characterizing the responses of thousands of single cells or cell clones presented to multiple drug conditions. We developed a new microfluidics-based “SMART” platform that is Simple to operate, able to generate a Massive single-cell array and Multiplex drug concentrations, capable of keeping cells Alive, Retainable and Trackable in the microchambers. These features are achieved by integrating a Microfluidic chamber Array (4320 units) and a six-Concentration gradient generator (MAC), which enables highly efficient analysis of leukemia drug effects on single cells and cell clones in a high-throughput way. A simple procedure produces 6 on-chip drug gradients to treat more than 3000 single cells or single-cell derived clones and thus allows an efficient and precise analysis of cell heterogeneity. The statistic results reveal that Imatinib (Ima) and Resveratrol (Res) combination treatment on single cells or clones is much more efficient than Ima or Res single drug treatment, indicated by the markedly reduced half maximal inhibitory concentration (IC50). Additionally, single-cell derived clones demonstrate a higher IC50 in each drug treatment compared to single cells. Moreover, primary cells isolated from two leukemia patients are also found with apparent heterogeneity upon drug treatment on MAC. This microfluidics-based “SMART” platform allows high-throughput single-cell capture and culture, dynamic drug-gradient treatment and cell response monitoring, which represents a new approach to efficiently investigate anticancer drug effects and should benefit drug discovery for leukemia and other cancers.

High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics

High-Throughput Functional Screening of Antigen-Specific T Cells Based on Droplet Microfluidics at a Single-Cell Level

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

Microfluidics guided by deep learning for cancer immunotherapy screening

Profiling of Immune-Cancer Interactions at the Single-Cell Level Using a Microfluidic Well Array.

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

High-throughput and multimodal profiling of antigen-specific T cells with a droplet-based cell-cell interaction screening platform

Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds

Self-Sterilizing and Regeneratable Microchip for the Precise Capture and Recovery of Viable Circulating Tumor Cells from Patients with Cancer.

Cancer-on-a-Chip for Modeling Immune Checkpoint Inhibitor and Tumor Interactions.

Genetic and Phenotypic Profiling of Single Living Circulating Tumor Cells from Patients with Microfluidics

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

Droplet microfluidic technology for single-cell high-throughput screening

Drug screening on digital microfluidics for cancer precision medicine

Evaluation of cancer immunotherapy using mini-tumor chips

Microdroplet-enhanced chip platform for high-throughput immunotherapy marker screening from extracellular vesicle RNAs and membrane proteins

A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids

Flow Rate Independent Multiscale Liquid Biopsy for Precision Oncology

Microfluidic Technologies in Advancing Cancer Research

An Integrated Microfluidics Platform with High-Throughput Single-Cell Cloning Array and Concentration Gradient Generator for Efficient Cancer Drug Effect Screening.